Immunomodulatory drugs alleviate l ‐dopa‐induced dyskinesia in a rat model of Parkinson's disease-Reference-Cited by-同舟云学术

Immunomodulatory drugs alleviate l ‐dopa‐induced dyskinesia in a rat model of Parkinson's disease

Published:2019-07-23 Issue:12 Volume:34 Page:1818-1830
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Boi Laura¹,Pisanu Augusta²,Greig Nigel H.³,Scerba Michael T.³,Tweedie David³,Mulas Giovanna⁴,Fenu Sandro¹,Carboni Ezio¹,Spiga Saturnino⁴,Carta Anna R.¹⁵

Affiliation:

1. Department of Biomedical Sciences University of Cagliari Cagliari Italy

2. CNR Institute of Neuroscience Cagliari Cagliari Italy

3. Drug Design & Development Section, Translational Gerontology Branch National Institute of Aging Baltimore Maryland USA

4. Department of Life and Environmental Sciences University of Cagliari Cagliari Italy

5. National Institute of Neuroscience (INN), University of Cagliari Cagliari Italy

Funder

Intramural research Program of the NIH, National institute on Aging

Intramural research Program of the University of Cagliari

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27799

Reference87 articles.

1. Linked Clinical Trials – The Development of New Clinical Learning Studies in Parkinson's Disease Using Screening of Multiple Prospective New Treatments

2. Drug repurposing: progress, challenges and recommendations

3. Thalidomide is an inhibitor of angiogenesis.

4. Thalidomide

5. A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroinflammation and Dyskinesia: A Possible Causative Relationship?;Brain Sciences;2024-05-20

2. Tianqi pingchan granule promotes recovery of glymphatic system function in a rat model of l-DOPA-induced dyskinesia;Journal of Traditional and Complementary Medicine;2024-04

3. Neuroplasticity in levodopa-induced dyskinesias: An overview on pathophysiology and therapeutic targets;Progress in Neurobiology;2024-01

4. The ratio of M1 to M2 microglia in the striatum determines the severity of L‐Dopa‐induced dyskinesias;Journal of Neurochemistry;2023-11-02

5. Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation;Frontiers in Immunology;2023-10-04